Background Children with frequent relapse and steroid dependent nephrotic syndrome (FRNS/SDNS) will experience frequent relapse with many complications due to the disease and toxicity of steroid therapy. One of the most common complications is obesity which is associated with significant health problems in childhood and important risk factor of adult morbidity and mortality. Objective To find out the prevalence of obesity in children with FRNS/SDNS. Methods A cross sectional study was conducted from November
A syndrome (NS) who have achieved remission from initial therapy will expefrequent relapsers. In managing children with primary NS, the difficult problems are the occurrence of frequent relapse, steroid dependent, and steroid resistant. 3, 4 Children with frequent relapse and steroid dependent nephrotic syndrome (FRNS/SDNS) will experience frequent relapse with many complications due to the disease as well as to the toxicity of high dose and long-term steroid therapy. One of the most common complications is obesity. Studies shows that the prevalence of obesity among steroid sensitive Obesity is associated with significant health problems in childhood and is an important early risk factor of adult morbidity and mortality.
Overweight in childhood and adolescence was associated with an increased risk of morbidity from coronary heart disease (CHD).
Considering the morbidity of obesity, it is important to know the prevalence of obesity in children with FRNS/SDNS so that prevention, early detection and management could be performed. We also collected data of children with infrequent relapse nephrotic syndrome (IRNS) as a comparison.
Methods
A cross-sectional study was conducted at the Nephrology Outpatients Clinic, Department of Child Health, Cipto Mangunkusumo Hospital characteristics of the subjects were collected from medical records of children with FRNS/SDNS the inclusion criteria. We included patients with the abnormalities which affected the anthropometric measurement (congenital anomaly, congenital heart disease, and neoplasm), children who received other medicines which affected the anthropometric measurement, or if parents refused to participate.
Body weight, height, and body fat mass measurement was performed on the subjects. The percentile) and body fat mass measurement. This study was approved by the Ethics Committee, Medical School, University of Indonesia.
Results
not recruit all children who fulfilled the inclusioncriteria because only one third of them who still had routine visits at theNephrology Outpatients Clinic.The rest had unknown address, already moved or died.
with a greater proportion in duration of prednisone of prednisone until the study was done in most of the Table 1 ). The prevalence of obesity according to BMI was (35) 25 (58) 18 (42) 30 (70) 11 (25) 2 (5) 16 (37) 12 (28) 15 (35) 5 (12) 28 (65) 10 ( obese subjects had range of time since the last dose of Table 3 ).
Discussion
In The prevalence of obesity based on BMI was previous studies which reported that the prevalence It could be happened due to difference in the inclusion criteria used. This study included all patients, either they were in prednisone therapy or the last exposure was more than a year, so that we found less subjects with obesity. Study by Leonard et al included subjects who had received glucocorticoid et al before the study. Other factors were the differences in geographic, race, nutrition, and sample size.
The prevalence of obesity in healthy children in Indonesia as reported by Meilany Susanti and particular elementary school, while Meilany only in particular elementary school which might have difference nutrition. The higher prevalence of obesity in FRNS/SDNS compared to healthy population showed the effect of glucocorticoid exposure. In this study, the prevalence of obesity based on body fat mass was higher than based on BMI. This was also reported by Tyrrell et al that the prevalence of Experts recommend BMI because it can be obtained easily and correlated strongly with body fat percentage. It is a clinically important measurement of body fat since it controls to some degree for the influence of height, allowing comparison of obesity status across age groups. Recommended international BMI classification has very high specificity but the sensitivity is very low in female adolescents. However, BMI does not take into account lean body mass or pubertal status and variation in body composition between different individuals and ethnicities. Interpretation of assessments of overweight in children using only BMI for age and gender should include the realization that some children may have relatively high weights primarily because of high lean mass rather than high body fat levels and this is more common among male adolescents. BMI may underpredict the prevalence of excess adiposity in children with disease state. The ability to measure actual adiposity would eliminate any potential misclassification based on BMI.
Among eight overweight subjects based on BMI, after measuring the body fat mass, we found only three who were overfat, while the rest were obese. Among 30 well-nourished subjects based on BMI, body fat measurement showed that eight were already overfat. This study suggested that obesity determination in children with FRNS/SDNS could not use BMI, especially for those who were being treated with prednisone or time since the last dose should be evaluated further.
Foster et al reported that subjects with SSNS had high adiposity, with a mean fat-mass-for-heightbased reference group, but lean mass was greater in the SSNS group. Rashid et al reviewed about growth and body composition in children with chronic kidney disease (CKD). These children may have abnormalities of their body composition (altered fat mass and lean mass according to their etiology) which may not be apparent on simple measurement of BMI. DXA data, corrected for height in children with CKD, demonstrated that BMI did not accurately reflect body composition, with patients exhibiting low lean mass with relatively high fat mass.
Studies by Foster et al and Rasyid et al may achieve remission was the end of the second week retention due to the disease or effect of glucocorticoid, although edema were not found clinically. From body fat mass measurement, we found that seven subjects far the alteration of their body composition (fat mass distributions and lean mass) still needs further investigation. Among subjects with time since the last dose the previous time-periods. It could not be determined due to the lack of data (weight and height) in the medical records and the cross-sectional study design performed.
In conclusion, the prevalence of obesity in FRNS/SDNS subjects based on body fat mass th percentile, while th percentile. Based on body fat mass measurement, all FRNS/SDNS th percentile are obese. percentages measured by dual-energy X-ray absorptiometry corresponding to recently recommended body mass index cutoffs for overweight and obesity in children and and body composition in children with chronic kidney
